Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Brain Tumor Market Global Briefing 2017

Brain Tumor Market Global Briefing 2017

From $1,000.00

Including: Chemotherapy, Immunotherapy, And Targeted Therapy Drugs.
Covering: Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Astra Zeneca


Clear selection
SKU: 2258. Category: .
Description

Brain Tumor Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global brain tumor market.

Description

The Brain Tumor Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The brain tumor market is one of the segments in the oncology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the brain tumor market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the brain tumor market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the brain tumor market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Chemotherapy, Immunotherapy, and Targeted Therapy drugs.

Companies Mentioned: Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Astra Zeneca.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Lung cancer Market Global Briefing 2017
Pancreatic cancer Market Global Briefing 2017
Breast cancer Market Global Briefing 2017
Prostate cancer Market Global Briefing 2017
Ovarian cancer Market Global Briefing 2017
Gastric Cancer Market Global Briefing 2017
Non-Small Cell Lung Cancer Market Global Briefing 2017
Colorectal Cancer Market Global Briefing 2017
Thyroid cancer Market Global Briefing 2017
Bladder Cancer Market Global Briefing 2017
Kidney Cancer Market Global Briefing 2017
Skin cancer Market Global Briefing 2017
Cervical Cancer Market Global Briefing 2017
Blood cancer Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Brain Tumor Market Characteristics
3. Brain Tumor Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Brain Tumor Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Brain Tumor Market Geography Split
6. Brain Tumor Market As A Proportion of Oncology Drugs Market, 2016, By Region
7. Brain Tumor Market As A Proportion of Oncology Drugs Market, 2016, By Country
8. Brain Tumor Market Segmentation
9. Brain Tumor Competitive Landscape
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Astra Zeneca
10. Key Mergers And Acquisitions In The Brain Tumor Market
11. Brain Tumor Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Brain Tumor Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Brain Tumor Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Brain Tumor Market, Split By Region, 2016, $ Billion
Table 4: Brain Tumor Market As A Proportion of Oncology Drugs Market, 2016, By Region
Table 5: Brain Tumor Market As A Proportion of Oncology Drugs Market, 2016, By Country
Table 6: Global Brain Tumor Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Brain Tumor Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Brain Tumor Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Brain Tumor Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Brain Tumor Market, Split By Region, 2016, $ Billion
Figure 4: Brain Tumor Market As A Proportion of Oncology Drugs Market, 2016, By Region
Figure 5: Brain Tumor Market As A Proportion of Oncology Drugs Market, 2020, By Country
Figure 6: Global Brain Tumor Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Brain Tumor Market, Split By Segments, 2016, $ Billion
Executive Summary
The brain tumor drugs market cover drugs that treat conditions related to brain tumor. These indications include Acoustic Neuroma, Pilocytic Astrocytoma, Anaplastic Astrocytoma, Chordoma, CNS Lymphoma, Craniopharyngioma, Oligodendroglioma, Choroid Plexus Papilloma, Meningioma, Pituitary Adenoma, Schwannomas, and Medulloblastoma, and Other Gliomas (Brain Stem Glioma and Ependymoma). Some of the major drugs in this market are Erlotinib, Geftinib, Bevacizumab, Cisplatin, Carmustine, and Temozolomide. Based on therepeutics, the market is segmented into chemotherapy, immunotherapy, and targeted therapy drugs.

The global brain tumor market was estimated to be around $1.8 billion as of 2016. The global brain tumor made up around 1.5% of the overall oncology drugs market in 2016. The brain tumor market was the tenth largest market in the global oncology drugs market in 2016.

Strategic Acquisitions
Strategic acquisitions of small companies by market leaders to strengthen their market position is one of the major trend in the market. For instance, in October 2016, Novagen acquired Glioblast for $1.6 million. It is an Australia based pharmaceutical company that focuses on R&D of Phase II-ready glioblastoma multiforme (GBM) candidate for brain tumor treatment. Novagen is licensing lioblastoma multiforme (GBM) candidate from Genentech. Novogen acquired rights to GDC-0084 from Genentech for $5 million upfront and also agreed to pay royalties on a percentage of net sales.
Get Customized Report
Please fill in your details. Our team will get back to you